InsiderClue
Stocks · Health care · Pharmaceutical Preparations

NRX Pharmaceuticals, Inc.

NRXP Clue Score26
United States Fiscal year ends December CIK 0001719406
$2.85 -1.38% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $2.85 −57.96% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 4 Dec 2017. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2018Operating income−1.0Net income0.1Fiscal year 2019Operating income−0.7Net income0.4 +517.9%Fiscal year 2020Operating income−51.4Net income−51.8 −12,777.2%EPS, diluted−1.51Fiscal year 2021Operating income−115.8Net income−93.1EPS, diluted−1.98Fiscal year 2022Operating income−44.3Net income−39.8EPS, diluted−0.60Fiscal year 2023Revenue0.0Operating income−27.8Net income−30.2Fiscal year 2024Revenue0.0Operating income−18.5Net income−25.1Fiscal year 2025Revenue1.2Operating income−16.2Net income−28.6
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue n/a n/a n/a n/a n/a 0.0 0.0 1.2
Growth
Operating income −1.0 −0.7 −51.4 −115.8 −44.3 −27.8 −18.5 −16.2
Net income 0.1 0.4 −51.8 −93.1 −39.8 −30.2 −25.1 −28.6
Growth +517.9% −12,777.2%
EPS, diluted n/a n/a −1.51 −1.98 −0.60 n/a n/a n/a
Growth

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2018Fiscal year 2019Fiscal year 2020Fiscal year 2021Fiscal year 2022Fiscal year 2023Fiscal year 2024Fiscal year 2025Operating margin−1,324.4%Net margin−2,336.5%
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin n/a n/a n/a n/a n/a n/a n/a −1,324.4%
Net margin n/a n/a n/a n/a n/a n/a n/a −2,336.5%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2018Operating cash flow−0.5Fiscal year 2019Operating cash flow−0.8Fiscal year 2020Operating cash flow−2.3Capital expenditure−0.0Free cash flow−2.3Fiscal year 2021Operating cash flow−37.7Capital expenditure−0.0Free cash flow−37.7Fiscal year 2022Operating cash flow−39.8Capital expenditure−0.0Free cash flow−39.8Fiscal year 2023Operating cash flow−21.7Capital expenditure−0.0Free cash flow−21.7Fiscal year 2024Operating cash flow−10.6Capital expenditure0.0Free cash flow−10.6Fiscal year 2025Operating cash flow−14.1
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −0.5 −0.8 −2.3 −37.7 −39.8 −21.7 −10.6 −14.1
Capital expenditure n/a n/a −0.0 −0.0 −0.0 −0.0 0.0 n/a
Free cash flow n/a n/a −2.3 −37.7 −39.8 −21.7 −10.6 n/a
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2018Shareholders’ equity5.0Fiscal year 2019Cash0.9Shareholders’ equity−4.8Fiscal year 2020Cash1.9Shareholders’ equity−43.8Fiscal year 2021Cash27.6Shareholders’ equity20.8Fiscal year 2022Cash20.1Total debt10.5Net cash (debt)9.5Shareholders’ equity7.4Debt to equity1.42Fiscal year 2023Cash4.6Total debt18.3Net cash (debt)−13.7Shareholders’ equity−11.7Fiscal year 2024Cash1.4Shareholders’ equity−23.2Fiscal year 2025Cash7.8Shareholders’ equity−15.9
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash n/a 0.9 1.9 27.6 20.1 4.6 1.4 7.8
Total debt n/a n/a n/a n/a 10.5 18.3 n/a n/a
Net cash (debt) n/a n/a n/a n/a 9.5 −13.7 n/a n/a
Shareholders’ equity 5.0 −4.8 −43.8 20.8 7.4 −11.7 −23.2 −15.9
Debt to equity n/a n/a n/a n/a 1.42 n/a n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
n/a n/a n/a n/a n/a 0.0 0.0 1.2
Growth
n/a n/a n/a n/a n/a n/a 0.0 0.5
n/a n/a 10.6 20.3 17.0 13.4 6.2 3.8
n/a n/a 11.4 74.9 27.3 14.2 13.5 13.1
−1.0 −0.7 −51.4 −115.8 −44.3 −27.8 −18.5 −16.2
Growth
0.1 0.5 −51.8 −93.1 −39.8 n/a n/a n/a
0.0 0.1 0.0 n/a n/a 0.0 0.0 0.0
0.1 0.4 −51.8 −93.1 −39.8 −30.2 −25.1 −28.6
Growth +517.9% −12,777.2%
Per share
n/a n/a −1.51 −1.98 −0.60 −3.98 −2.36 −1.34
n/a n/a −1.51 −1.98 −0.60 n/a n/a n/a
Growth
n/a n/a 34.3 46.9 65.8 7.6 10.6 21.4
n/a n/a 34.3 46.9 65.8 n/a n/a n/a
Growth +36.9% +40.2%

Five years in brief

Worked out from the figures above, not from a press release
  • A net loss in 6 of 8 years on file.